We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

This study has been terminated.
(The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01701934
First Posted: October 5, 2012
Last Update Posted: November 11, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Innovair
Takeda
Information provided by (Responsible Party):
Laval University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)

To Top